缺血性卒中患者LDL-C较基线降低≥50%的预后获益
该回顾性队列研究利用韩国国民健康保险数据库纳入2014—2022年急性缺血性卒中住院患者,按是否达到绝对LDL-C<70 mg/dL及相对较基线降低≥50%分为四组。主要复合终点为复发性卒中、心肌梗死和全因死亡。结果显示,未达到≥50%降低者主要终点风险显著升高,且独立于是否达到绝对LDL-C目标。
要点
- 缺血性卒中后约30%患者达到LDL-C较基线降低≥50%。
- 未达≥50%降低者主要终点风险升高,即使LDL-C已<70 mg/dL。
- 降脂策略应兼顾绝对目标与相对降幅。
核心结论
- LDL-C较基线降低≥50%与缺血性卒中后次要心血管事件风险降低独立相关。
研究设计与样本
- 回顾性队列研究,利用韩国国民健康保险数据库纳入2014—2022年急性缺血性卒中住院患者89,414例,分析136,427次卒中后LDL-C测量,平均随访5.72±2.40年。
主要发现
- 随访期间达到LDL-C较基线降低≥50%的患者比例维持在约30%。
- 以同时达到LDL-C<70 mg/dL和≥50%降低为参照,LDL-C<70 mg/dL但未达≥50%降低组主要终点调整风险比1.12(95%CI 1.06-1.18)。
- LDL-C≥70 mg/dL且未达≥50%降低组主要终点调整风险比1.28(95%CI 1.23-1.34)。
- 亚组分析按性别、年龄、基线LDL-C水平及推测心源性栓塞来源分层,结果一致。
临床怎么用
- 对缺血性卒中患者应同时关注LDL-C绝对目标(<70 mg/dL)和较基线降低≥50%的相对目标。
- 需采取更强化和多方面的降脂策略以改善长期预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Current secondary atherosclerotic cardiovascular disease prevention guidelines recommend both a ≥50% reduction in low-density lipoprotein cholesterol (LDL-C) from baseline and an absolute LDL-C goal (<70 or <55 mg/dL). Stroke-specific guidelines primarily emphasize only an absolute LDL-C goal, and the independent clinical impact of achieving a ≥50% reduction remains unclear in patients with ischemic stroke. This study aimed to evaluate whether achieving a ≥50% LDL-C reduction provides prognostic benefit independent of attaining an absolute LDL-C goal in patients with ischemic stroke. METHODS: This retrospective cohort study included patients admitted for acute ischemic stroke (2014-2022) using the Korean National Health Insurance Database in South Korea. LDL-C status over time was derived from serial national health examinations following the index stroke. Patients were categorized into 4 groups according to attainment of absolute (<70 mg/dL) and relative (≥50% reduction from baseline) LDL-C goals. The primary outcome was a composite of recurrent stroke, myocardial infarction, and all-cause death, analyzed using time-varying Cox regression. RESULTS: Among 89,414 patients, 136,427 poststroke LDL-C measurements were analyzed over a mean follow-up of 5.72 ± 2.40 years. Throughout the follow-up period, the proportion of patients achieving a ≥50% LDL-C reduction from baseline remained at approximately 30%. Using the optimal group (achieving both <70 mg/dL and ≥50% reduction) as the reference, the risk of the primary outcome was significantly higher in groups failing to achieve a ≥50% reduction, regardless of attainment of the absolute LDL-C level (<70 mg/dL): adjusted hazard ratio [95% CI] 1.12 [1.06-1.18] for the <70 mg/dL and <50% reduction group and 1.28 [1.23-1.34] for the ≥70 mg/dL and <50% reduction group. Results were consistent across subgroups stratified by sex, age, baseline LDL-C level, and the presence of presumed cardioembolic source. DISCUSSION: Achieving a ≥50% reduction in LDL-C from baseline was independently associated with a lower risk of secondary cardiovascular events. A substantial proportion of patients with ischemic stroke fail to achieve optimal LDL-C reduction; thus, more intensive and multifaceted lipid-lowering strategies focusing on both absolute and relative LDL-C reduction may lead to improved long-term outcomes.
引用
- Baik M, Jeon J, Yoo J, et al. Effect of a ≥50% Reduction in Low-Density Lipoprotein Cholesterol From Baseline in Patients With Ischemic Stroke. Neurology. 2026. PMID: 42623575. doi:10.1212/WNL.0000000000218491
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。